Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway
暂无分享,去创建一个
T. Choueiri | A. Turchin | R. McKay | L. Goyal | Jonathan S. Williams | O. Hamnvik | M. Kaymakcalan | Michael Davis